AI is reshaping global industries, but for smart healthcare startups, the biggest challenge remains how to translate technology into real-world clinical markets beyond isolated experiments. On December 18, the Taiwan Stock Exchange (TWSE) and international venture accelerator SparkLabs Taiwan co-hosted the Smart Health Capital Forum, bringing together representatives from medical startups, global pharmaceutical companies, and tech firms to share practical experiences in launching AI medical products and discuss balancing commercialization with clinical application.